KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Gains from Investment Securities (2019 - 2025)

Historic Gains from Investment Securities for LifeMD (LFMD) over the last 10 years, with Q2 2025 value amounting to $1.2 million.

  • LifeMD's Gains from Investment Securities rose 1862.57% to $1.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.2 million, marking a year-over-year decrease of 4818.83%. This contributed to the annual value of $682333.0 for FY2024, which is 33973.82% up from last year.
  • As of Q2 2025, LifeMD's Gains from Investment Securities stood at $1.2 million, which was up 1862.57% from $725000.0 recorded in Q1 2025.
  • In the past 5 years, LifeMD's Gains from Investment Securities ranged from a high of $4.4 million in Q3 2024 and a low of -$2.6 million during Q4 2022
  • Over the past 5 years, LifeMD's median Gains from Investment Securities value was $1.3 million (recorded in 2024), while the average stood at $1.2 million.
  • Per our database at Business Quant, LifeMD's Gains from Investment Securities tumbled by 9694.83% in 2023 and then skyrocketed by 691523.86% in 2024.
  • Over the past 5 years, LifeMD's Gains from Investment Securities (Quarter) stood at $2.1 million in 2021, then plummeted by 224.8% to -$2.6 million in 2022, then soared by 102.37% to $62053.0 in 2023, then crashed by 265.37% to -$102618.0 in 2024, then soared by 1308.37% to $1.2 million in 2025.
  • Its Gains from Investment Securities was $1.2 million in Q2 2025, compared to $725000.0 in Q1 2025 and -$102618.0 in Q4 2024.